Dexamethasone reduces vascular endothelial growth factor in comparison to placebo in post-operative chronic subdural hematoma samples: A target for future drug therapy?

BACKGROUND: Chronic subdural hematoma (CSDH) is a collection of blood and fluid that arises on the brain surface due to a combination of trauma and/or inflammation. The mainstay of treatment is surgical drainage, but CSDH can recur. Dexamethasone has been shown to reduce CSDH recurrence, but its mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Edlmann, Ellie, Giorgi-Coll, Susan, Thelin, Eric P., Hutchinson, Peter J., Carpenter, Keri L. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492873/
https://www.ncbi.nlm.nih.gov/pubmed/36158966
http://dx.doi.org/10.3389/fneur.2022.952308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492873/
https://www.ncbi.nlm.nih.gov/pubmed/36158966
http://dx.doi.org/10.3389/fneur.2022.952308

Ejemplares similares